a76df2f9_docrine_Cancer_Research___CFCF__Status
[Title] A Phase I, Open-Label, Dose Escalation Study of Daily Dosing With BB-10901 [Phase] I [Conditions] Neuroendocrine Tumor [State] TX [Status] 
Not Recruiting
N o t R e c r u i t i n g
E n r o l l i n g
Clinical Trials Finder | Carcinoid and Pancreatic Neuroendocrine Cancer Research | CFCF
Status